# The Use of Sugammadex in the Critically Ill

> **NCT03791801** · NA · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 50 (estimated)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine
- **DRUG:** Rocuronium
- **DRUG:** Glycopyrrolate

## Key facts

- **NCT ID:** NCT03791801
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03791801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03791801, "The Use of Sugammadex in the Critically Ill". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03791801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*